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OBJECTIVES This study determined the relative efficacy of aerobic exercise (daily walking) and moderate
dietary sodium restriction (sodium intake ,100 mmol/day) for reducing systolic blood
pressure (SBP) and pulse pressure (PP) in postmenopausal women with elevated initial levels,
and the potential role of reductions in large artery stiffness in these changes.
BACKGROUND Lifestyle behaviors are recommended for lowering blood pressure (BP) in adults with elevated
baseline levels, but there is little information as to the relative efficacy of different
interventions or the mechanisms underlying their potential beneficial effects.
METHODS After baseline measurements and random assignment, 35 nonmedicated healthy postmeno-
pausal women with SBP between 130 and 159 mm Hg completed three months of either
aerobic (walking) exercise (n 5 18; 62 6 9 years, mean 6 SD) or moderate dietary sodium
restriction (SR) (n 5 17; 65 6 10 years, mean 6 SD).
RESULTS Body mass and composition, plasma volume, and fasting concentrations of metabolic
coronary risk factors did not differ between the groups at baseline or change with intervention.
Systolic BP and PP at rest decreased with both exercise and SR (p , 0.05); however, the
reductions were three- to fourfold greater with SR (p , 0.05). Sodium restriction, but not
exercise, also reduced 24-h SBP and PP (p , 0.05). Aortic pulse wave velocity (PWV) and
carotid augmentation index were reduced only with SR (p , 0.05). Changes in SBP and PP
at rest and over 24 h correlated with the corresponding changes in aortic PWV (r 5 0.53 to
0.61, p , 0.01).
CONCLUSIONS Moderate SR lowers SBP and PP in postmenopausal women with elevated baseline levels
more than does daily walking. The greater blood pressure reductions with SR may be
mediated in part by a decrease in the stiffness of the large elastic arteries. (J Am Coll Cardiol
2001;38:506–13) © 2001 by the American College of Cardiology
The stiffness of the large elastic arteries in cardiothoracic
(central) circulation increases with age in adult humans,
although the muscular peripheral arteries are not obviously
affected (1–4). The increase in central arterial stiffness
results in progressive age-associated elevations in systolic
blood pressure (SBP) and pulse pressure (PP) (5–7). Im-
portantly, the increases in SBP and PP after age 50 are
much greater in women than in men (5,7).
The elevations in SBP and PP with age are clinically
significant. Based on relative risk, SBP and PP represent the
single largest contributor to overall cardiovascular disease
(CVD) risk in middle-aged and older adults (7–11). Even
modest elevations in SBP above 120 mm Hg are associated
with increased CVD risk (7,9,10).
Lowering SBP reduces CVD mortality in middle-aged
and older patients with elevated baseline levels (9,12).
Current treatment guidelines for this population emphasize
lifestyle modifications such as regular exercise, weight loss
and dietary changes as the initial therapeutic approach
(13,14). Of these, regular aerobic exercise might be unique
because in hypertensive adults it may both lower SBP and
produce other benefits such as improvements in fitness and
changes in other health behaviors (15,16). However, there is
currently little information from randomized trials in
middle-aged and older adults, particularly postmenopausal
women, upon which to base treatment recommendations on
the use of aerobic exercise. Moreover, to our knowledge
there are no data as to the relative efficacy of regular exercise
compared with other currently recommended behavioral
(lifestyle) interventions for lowering SBP in this clinically
important population. In this context, dietary sodium re-
striction (SR) lowers SBP in adults with elevated baseline
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levels, and the magnitude of the reduction appears to be
greater in older patients (17,18).
If aerobic exercise and SR lower SBP in middle-aged and
older adults, reductions in central arterial stiffness could play
an important mechanistic role. Cross-sectional group com-
parisons indicate that both regular exercise and reduced
sodium intake are associated with lower stiffness in the large
elastic arteries of the central circulation (3,4,19). However,
whether habitual exercise and/or SR reduce central arterial
stiffness in middle-aged and older adults with chronic
elevations in SBP is unknown.
Accordingly, the primary experimental aims of the
present investigation were to determine: 1) the relative
efficacy of regular aerobic exercise and moderate SR in
lowering SBP and PP in postmenopausal women with
elevated baseline SBP, and 2) whether one of these inter-
ventions is more efficacious in reducing central arterial
stiffness, and whether such reductions are related to the
corresponding decreases in SBP and PP.
METHODS
Subjects. Subject inclusion criteria were postmenopausal
status (amenorrheic for at least two years and follicle
stimulating hormone plasma concentrations .40 IU/l);
$50 years of age; SBP in the high normal or Stage 1
hypertensive range (130 to 159 mm Hg) with diastolic BP
(DBP) #99 mm Hg (i.e., Stage 1 hypertensive range or
below) during sitting rest; no antihypertensive medications
taken either two months prior to screening (n 5 1) or ever
(n 5 35); absence of other chronic disease (based on blood
chemistries, medical history, physical examination, and
resting and maximal exercise electrocardiogram); not on a
low-sodium diet nor having performed regular exercise
during the preceding two years; not smoking; and a body
mass index (BMI) ,35. A total of 35 women completed a
three-month intervention involving either walking exercise
(EX; n 5 18) or moderate SR (n 5 17). Four women (3
EX, 1 SR) dropped out of the interventions owing to
personal reasons. Six of the women who completed each
intervention had baseline SBP in the high normal (130 to
139 mm Hg) range, whereas the others had initial values in
the Stage 1 systolic hypertensive range (140 to 159 mm Hg).
Nine of the 17 women in the SR group and 10 of the 18
women in the EX group were on hormone replacement
therapy. Of the subjects completing the interventions, 34
were white and 1 was Asian. The Asian subject completed
the SR condition and demonstrated changes in BP similar
to the mean changes for her group. The nature, purpose,
and risks of the study were explained to each subject before
written informed consent was obtained.
Experimental design. A parallel group design with an
active treatment control group (i.e., SR) was employed
rather than a placebo control group; the latter could be
considered unethical in that it would deny patients either
the experimental or usual care treatment likely to lower
CVD risk. Moreover, stable baseline resting blood pressure
(BP) values were documented in each subject prior to
randomized assignment (see below), thus minimizing the
need for a placebo control group for the key outcome
variable. Subjects satisfying the inclusion criteria underwent
baseline measurements and subsequently were randomly
assigned to either the EX or SR group. The duration of each
condition was ;13 weeks (3 months). During these inter-
vention periods subjects were asked to maintain their
preenrollment body weight; they reported to the laboratory
every two weeks for intervention-specific counseling, com-
pliance monitoring, and measurements of body weight and
casual BP at rest. At the end of their assigned condition,
subjects again underwent the measurements performed at
baseline.
Measurements. Treadmill exercise testing was performed
using a modified Balke walking protocol as described in
detail previously (20). Body composition was determined by
dual energy X-ray absorptiometry. Total caloric intake and
its composition, including sodium intake, were estimated
from food records analyzed by experienced research dieti-
tians. Urinary sodium excretion was determined from 24-h
urine collections. Plasma volume was measured using the
modified Evans blue dye procedure as described previously
(21). Fasting plasma concentrations of glucose, insulin,
lipids and lipoproteins, and fibrinogen were measured by the
Core Laboratory of the University of Colorado Adult
General Clinical Research Center using conventional pro-
cedures (3).
Casual BP at rest was recorded in the upright seated
position between 7 and 11 AM after an overnight fast in
strict accordance with American Heart Association guide-
lines as described in detail previously by our laboratory
(22,23). Recordings were obtained in triplicate in three
separate sessions at least one week apart in order to establish
the stability of baseline levels; this was repeated at end-
intervention. The mean values from the three sessions were
used to establish pre- and end-intervention levels. To avoid
any possibility of investigator bias, recordings were obtained
over the brachial artery with a semi-automated device
(Dinamap XL, Critikon, Florida). Casual recordings of BP
at rest also were obtained manually using auscultation over
the brachial artery with a random zero sphygmomanometer
Abbreviations and Acronyms
AI 5 augmentation index
BMI 5 body mass index
BP 5 blood pressure
CVD 5 cardiovascular disease
DBP 5 diastolic blood pressure
EX 5 aerobic exercise
MAP 5 mean arterial blood pressure
PP 5 pulse pressure
PWV 5 pulse wave velocity
SBP 5 systolic blood pressure
SR 5 dietary sodium restriction
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(Hawksley and Sons, West Sussex, United Kingdom).
These values were used to independently confirm the results
obtained with the semi-automated device. In addition, BP
recordings were obtained over a 24-h period of normal daily
activity using a noninvasive ambulatory monitor (Model
90207, Spacelabs, Redlands, Washington) as described in
detail previously (22,23). The following values were ob-
tained: 24-h, daytime, and nighttime SBP and DBP; SBP
load (% of recordings .140 mm Hg) and DBP load (% of
recordings .90 mm Hg); SBP and DBP variability (SD of
24-h, daytime, and nighttime values); and day-to-night
differences (nocturnal decline) in SBP and DBP.
Details and reliability of the noninvasive measurements of
arterial stiffness (carotid augmentation index [AI] aortic and
arm pulse wave velocities [PWV]) have been described in
detail previously (3). Because of logistical and technical
reasons, measurements of AI and PWV were obtained
before and at the end of the interventions on only 30 (14
EX, 11 SR) and 24 (14 EX, 16 SR) of the subjects,
respectively. For all measurements, analyses were performed
by the same investigator who was blinded to the group
assignment of the subject.
Aerobic exercise. Following orientation, subjects exercised
on their own using a general program that has been
described previously (22). During the initial few weeks,
subjects were asked to walk for ;30 min/day at an intensity
of 40% to 50% of their individually determined maximal
heart rate for three to four days/week. As their exercise
tolerance increased, subjects were asked to increase their
walking to 40 to 45 min/day at an intensity equivalent to
65% to 80% of maximal heart rate for as many days a week
as possible. Compliance to the exercise program was docu-
mented using heart rate monitors combined with activity
logs that were returned to the laboratory for analysis every
two weeks during the intervention period. Subjects assigned
to this condition were asked not to alter their diet from their
baseline levels.
Dietary sodium restriction. Moderate SR was employed
using procedures described previously for peer-reviewed
clinical trials (24,25). In accordance with current Joint
National Committee (on Prevention, Detection, Evaluation
and Treatment of High Blood Pressure) VI guidelines (14),
subjects were asked to reduce their sodium intake to ,100
mmol/day (,2.4 g of sodium or ,6 g of sodium chloride)
without altering their total caloric intake or otherwise
changing their diet composition. After an initial orientation,
subjects in this condition visited the laboratory every two
weeks to receive dietary education and counseling by a
research dietitian. This was exactly the same frequency at
which EX group subjects underwent monitoring. Compli-
ance to the intervention was documented by determining
the reductions in dietary sodium intake as well as 24-h
urinary sodium excretion rates. Subjects assigned to this
intervention were asked to maintain their habitual activity at
their individual baseline (sedentary) levels.
Data analysis and statistics. Differences at baseline and
changes over the three-month EX and SR intervention
periods in the dependent variables were assessed by two-way
repeated measures analysis of variance (ANOVA). When
indicated by a significant main effect or interaction, specific
mean comparisons were performed to identify significant
differences within and between each intervention. Relations
between variables of interest were determined by univariate
correlation and regression analysis. Analyses were per-
formed only on subjects who completed the interventions.
Data are presented as mean 6 SD. Statistical significance
was set at p , 0.05.
RESULTS
Subject characteristics. The mean ages of the women in
the EX and SR groups were 62 6 9 and 65 6 10 years,
respectively (NS). No differences were seen in any subject
characteristic in the two groups at baseline, nor did any of
these variables change in response to either intervention
(Table 1). Total caloric intake, fat, carbohydrate, and
protein macronutrient diet composition, and calcium, mag-
nesium, and potassium micronutrient diet composition did
not differ between the groups at baseline, and they did not
change with either intervention (data not shown).
Intervention compliance. Subjects in the EX group
walked for 5.8 6 1.1 days/week, 40 6 4 min/day, at an
intensity equivalent to 70 6 2% of their maximal heart rate
over the three-month intervention period. Resting heart
rate and submaximal exercise heart rate and perceived
exertion were reduced, and maximal treadmill walking time
was increased, in response to EX (all p , 0.05), but all were
unchanged with SR (Table 2). Maximal oxygen consump-
tion was not significantly changed with either intervention
(Table 2). Urinary sodium excretion and dietary sodium
intake were reduced over the three-month period in the SR
group (both p , 0.05) but were unchanged in the EX group
(Table 2).
Blood pressure. There were no group differences in base-
line casual BP at rest (Fig. 1). The manual and semi-
automated measures provided similar information for these
baseline values as well as for the changes in response to the
interventions (Fig. 1). Significant main effects and interac-
tions were observed for each of the casual BP values: SBP,
DBP, PP, and mean arterial blood pressure (MAP) were
lower after compared with before EX and SR (all p , 0.05;
Fig. 1); however, the decreases were consistently greater in
response to SR compared with EX, especially for SBP (;16
vs. 5 mm Hg) and PP (;10 vs. 2 mm Hg) (both p , 0.05).
In EX the numbers of subjects with DSBP .22, 22 to 2,
and .12 mm Hg were 10 (55%), 3 (17%) and 5 (28%),
respectively, whereas with SR it was 15 (88%), 2 (12%) and
0; thus, there was a higher percentage of “responders” to SR
than to EX. The mean decreases in BP with SR were
consistently greater (all p , 0.05) for the subgroup of
women with Stage 1 systolic hypertension at baseline
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compared with the subgroup of women with initial SBP
values in the high normal range; for EX the differences were
not significant owing to the smaller reductions in BP
associated with that intervention. In women taking hor-
mone replacement compared with those not taking hor-
mone replacement therapy, no baseline differences were
seen in BP, nor were any differences detected in their
responses to the respective interventions.
There were no group differences in baseline 24-h, day-
time or nighttime ambulatory BP (Fig. 2). The 24-h SBP,
DBP, MAP and PP levels were lower after compared with
before SR due primarily to reductions in daytime levels (all
p , 0.05; Fig. 2); nighttime levels were not significantly
changed. In contrast, 24-h BP was not changed by EX. As
such, all of the reductions in ambulatory BP with SR were
greater than in response to EX (interaction p , 0.05). As
was the case with casual BP at rest, the decreases in 24-h
and daytime BP generally were greater in the women with
Stage 1 systolic hypertension at baseline compared with
those with values initially in the high normal range. More-
over, there was no difference in any ambulatory-determined
BP value at baseline in women taking hormone replacement
compared with women not taking hormone replacement
therapy, nor were the responses to either intervention
different in those two subgroups.
There were no baseline group differences in ambulatory-
determined BP loads, variabilities or nocturnal declines.
The SR decreased 24-h SBP load by ;35% (53 6 26% vs.
35 6 24%, p , 0.01) owing to a reduction in daytime SBP
load (66 6 27% vs. 45 6 32%, p , 0.01) and a tendency for
a decrease in nighttime SBP load (23 6 27% vs. 10 6 19%,
p 5 0.06). The SR tended to reduce 24-h (21 6 27% vs.
12 6 19%, p 5 0.06) and daytime (26 6 22% vs. 16 6 16%,
p 50.06) DBP loads. Also, SR reduced 24-h SBP variability
(15 6 3 mm Hg vs. 12 6 4 mm Hg, p , 0.05) due to a
reduction in daytime SBP variability (13 6 2 mm Hg vs.
Table 2. Responses to the Dietary Sodium Restriction and Exercise Interventions
Intervention
Exercise Sodium Restriction
Preintervention Postintervention Preintervention Postintervention
Urinary sodium excretion
(mmol/day)
119 6 48 132 6 49 124 6 46 86 6 32*
Sodium intake (mg/day) 2851 6 1149 2923 6 1118 2685 6 559 1421 6 512*
Resting heart rate (beats/min) 71 6 7 68 6 8* 66 6 10 66 6 9
Submaximal exercise heart
rate (beats/min) (workload
;70% of baseline V˙O2max)
153 6 10 143 6 13* 144 6 9 143 6 14
Submaximal rating of
perceived exertion
16.2 6 1.5 14.4 6 1.5* 16.6 6 1.5 16.6 6 2.0
Maximal treadmill time (min) 9.7 6 1.6 10.4 6 2.4* 10.4 6 2.3 10.2 6 2.3
V˙O2max (ml/kg/min) 21.3 6 4.1 22.4 6 4.7 20.0 6 4.5 20.0 6 4.3
*Change from baseline p , 0.05. Values are mean 6 SD.
Table 1. Selected Subject Characteristics
Intervention
Exercise Sodium Restriction
Preintervention Postintervention Preintervention Postintervention
Body mass (kg) 72.4 6 12.3 72.0 6 12.8 73.0 6 10.5 72.8 6 10.3
Body fat (%) 41.8 6 5.1 41.2 6 6.3 42.1 6 8.3 42.3 6 8.5
Fat-free mass (kg) 41.6 6 4.5 41.7 6 4.4 41.7 6 4.2 41.4 6 4.1
BMI (kg/m2) 28.0 6 4.3 27.9 6 4.4 28.1 6 4.9 28.0 6 4.8
Waist circumference (cm) 89.9 6 11.5 89.7 6 11.3 92.2 6 12.8 92.4 6 12.9
Waist:hip ratio 0.83 6 0.06 0.82 6 0.06 0.85 6 0.08 0.85 6 0.08
Fibrinogen (g/l) 3.2 6 0.9 3.2 6 0.9 3.4 6 0.9 3.5 6 0.9
Total cholesterol (mmol/l) 5.1 6 0.8 5.0 6 0.7 5.2 6 0.9 5.2 6 0.9
HDL (mmol/l) 1.6 6 0.5 1.6 6 0.5 1.5 6 0.4 1.4 6 0.4
HDL3 (mmol/l) 1.2 6 0.3 1.3 6 0.3 1.2 6 0.2 1.2 6 0.3
HDL2 (mmol/l) 0.3 6 0.3 0.4 6 0.5 0.3 6 0.2 0.2 6 0.2
LDL (mmol/l) 2.7 6 0.6 2.7 6 0.6 3.0 6 0.8 3.0 6 0.8
Triglycerides (mmol/l) 1.5 6 0.6 1.6 6 0.7 1.7 6 0.7 1.8 6 0.9
Insulin (pmol/l) 46.2 6 18.3 48.6 6 23.7 39.6 6 16.7 38.4 6 15.3
Glucose (mmol/l) 5.2 6 0.5 5.2 6 0.4 5.1 6 0.5 5.1 6 0.5
Plasma volume (ml) 2911 6 465 3001 6 351 3038 6 116 3120 6 312
Values are mean 6 SD.
BMI 5 body mass index; HDL 5 high density lipoprotein; LDL 5 low density lipoprotein.
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10 6 2 mm Hg, p , 0.01); nighttime SBP variability and
DBP variabilities were unchanged. In contrast, EX had no
influence on either BP load or variability. Neither interven-
tion altered the nocturnal decline in BP.
There were no significant correlations between compli-
ance to either intervention and the corresponding reduc-
tions in BP.
Arterial stiffness. No baseline group differences were seen
in any measure of arterial stiffness (Fig. 3). Carotid AI and
aortic PWV (both p , 0.05) were reduced by SR but had no
effect on arm PWV. In contrast, EX did not alter any
measure of arterial stiffness.
Relations between reductions in BP and arterial stiffness.
Among the pooled individual subjects, Daortic PWV was
significantly (all p , 0.01 or better) related to Dcasual SBP
(r 5 0.53), Dcasual PP (r 5 0.58), D 24-h SBP (r 5 0.61),
D24-h PP (r 5 0.57), D24-h DBP (r 5 0.59), and D24-h
MAP (r 5 0.61). The Dcarotid AI was significantly (all p ,
0.01 or higher) related to both Dcasual SBP (r 5 0.49) and
Dcasual PP (r 5 0.46).
DISCUSSION
The key findings from the present investigation were as
follows. First, in otherwise healthy postmenopausal women
with elevated SBP, SR lowered BP at rest more than did
EX. Second, SR, but not EX, was effective in reducing 24-h
levels of BP, as well as SBP load and variability. Third, SR
reduced the stiffness of the large elastic arteries in the central
circulation, whereas EX did not obviously do so in this
population. Finally, the reductions in central arterial stiff-
ness correlated with the corresponding reductions in SBP
and PP, suggesting a potential mechanistic role in the
hypotensive effects of SR. Overall, our results support the
view that SR is more efficacious for lowering resting and
24-h BP and large artery stiffness than is EX in this highly
prevalent, clinically important population.
Exercise intervention. The reductions in resting BP ob-
served with EX were significant, although slightly less than
what we had observed in a preliminary investigation in a
similar population of women (22). This previous study,
Figure 1. Mean 6 SD changes in arterial blood pressure at rest measured either by a semiautomated device (Dinamap) or manually (Random Zero) in
response to aerobic exercise and dietary sodium restriction. Baseline values are shown above each bar. *Change from baseline p , 0.05; †p , 0.05 vs. aerobic
exercise. DBP 5 diastolic blood pressure; PP 5 pulse pressure; SBP 5 systolic blood pressure.
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however, was not a randomized trial. Moreover, the reduc-
tions in casual resting BP observed in the present study are
well within the range previously reported in hypertensive
adult humans in response to regular aerobic exercise (16).
The facts that our population included women with high
normal baseline SBP and normal DBP, and that nonhyper-
tensive adults often demonstrate smaller responses to EX
than their hypertensive counterparts (16), also may have
contributed to our results. Moreover, it is possible that the
higher exercise frequency in the present study (;6 days/
week) compared with our previous investigation (;3 days/
week) could have played a role (the influence of essentially
daily exercise on BP has not been studied to our knowl-
edge). Consistent with the findings of our earlier study (22),
EX did not lower 24-h BP in the present investigation.
Dietary sodium restriction. The Trial of Nonpharmaco-
logic Interventions in the Elderly (TONE) has shown that
SR is an effective surrogate for BP control in some older
patients on antihypertensive drug therapy (25). The results
of the present study extend these previous findings in several
ways. First, we have shown that SR is an effective lifestyle
intervention for lowering resting SBP, DBP, and PP in
postmenopausal women with mild to moderate elevations in
baseline resting SBP who are not currently on antihyper-
tensive medications. Second, the response is consistent, with
;90% of the subjects demonstrating .2 mm Hg reduction
in SBP. Third, the magnitude of the reductions in SBP and
PP with SR can be impressive in this population. For
example, the mean 16 mm Hg decrease in resting SBP in
the present study was at least twofold greater than that
Figure 2. Mean 6 SD changes in ambulatory-determined 24-h, daytime, and nighttime systolic blood pressure (SBP), diastolic blood pressure (DBP), and
arterial pulse pressure (PP) in response to aerobic exercise and dietary sodium restriction. Baseline values are shown above each bar. *Change from baseline
p , 0.05; †p , 0.05 vs. aerobic exercise.
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observed previously (17,18,26,27). This occurred despite the
fact that our study sample included a number of subjects
with initial SBP values in the normotensive range, and this
may have been the result, at least in part, of: a) excellent
compliance to the intervention, b) the female gender of the
sample (27), and c) the moderate level of sodium intake of
the subjects at baseline, reductions from which are associ-
ated with greater decreases in SBP than are high baseline
levels (27).
Fourth, in contrast to EX, SR lowered 24-h SBP, DBP,
and PP. Similarly SR, unlike EX, reduced the mean daily
SBP load and variability, which are independent predictors
of CVD (28,29). Finally, these consistent and marked
BP-lowering effects of SR were not obviously dependent on
corresponding changes in body weight or composition, diet,
or other CVD risk factors. We also found that hormone
replacement therapy status, an increasingly important issue
in this population, does not modulate these SR-induced
reductions in resting BP.
Role of arterial stiffness. We observed significant reduc-
tions with SR in measures that reflect largely (aortic PWV)
or in part (carotid AI) the stiffness of the large elastic
arteries in the central circulation, whereas EX had no effect.
Neither intervention affected peripheral arterial stiffness,
which is not increased with age (1,3). Importantly, the
changes in resting and 24-h SBP and PP consistently
correlated with the corresponding changes in one or both
measures of central arterial stiffness. These relations were
stronger and more robust with aortic PWV, a more precise
measure of the stiffness of the large elastic arteries in the
central circulation per se than carotid AI. Associations
between absolute levels of BP and measures of central
arterial stiffness have been noted previously in cross-
sectional comparisons of subjects differing in dietary sodium
intake (19). To our knowledge, however, the present inves-
tigation is the first to provide experimental evidence for an
association between these events in response to an interven-
tion. As such, our findings provide initial support for the
hypothesis that reductions in central arterial stiffness may
play a mechanistic role particularly in the SBP- and PP-
lowering effects of SR. It should be noted, however, that the
decreases in mean BP with SR may have contributed to the
reduction in aortic PWV independent of any SR-evoked
changes in the intrinsic mechanical properties of the aorta.
Clinical implications. Our results are noteworthy in at
least two ways. First, elevated SBP is prevalent in this
population, particularly in the high normal and Stage 1
systolic hypertensive ranges (7). Given the number of
postmenopausal women in the future based on current
demographic projections, an increasing portion of the over-
all BP-related CVD risk in middle-aged and older adults
will be contributed by this group. Second, lifestyle (behav-
ioral) interventions are the recommended first-line thera-
peutic approach for middle-aged and older adults with mild
to moderate elevations in SBP (13,14). As such, determin-
ing the relative efficacy of two of the most widely recom-
mended lifestyle interventions, EX and SR, for lowering
SBP in this population provides new insight for health
professionals interested in BP control. Moreover, the fact
that SR lowers 24-h SBP and PP mean levels, and SBP load
and variability, all of which are significant independent
predictors of CVD risk (28–31), further supports its clinical
use in this patient population. Finally, the results of the
present study provide new evidence supporting a mechanis-
tic role for reductions in central arterial stiffness in the
hypotensive effects of SR.
There are, however, at least two limitations of our study
related to clinical implications. First, the population studied
was almost entirely Caucasian. African-American and other
minority women may respond differently to these interven-
tions. Second, the three-month duration of our interven-
tions precludes extrapolation of the results to long-term BP
control, which obviously is the ultimate goal of therapy.
Conclusions. In postmenopausal women with elevated
baseline SBP, SR has a greater hypotensive effect on resting
and 24-h BP than EX. The greater reductions in SBP and
Figure 3. Mean 6 SD changes in carotid augmentation index (AI), aortic pulse wave velocity (PWV), and arm PWV in response to aerobic exercise and
dietary sodium restriction. Baseline values are shown above each bar. *Change from baseline p , 0.05.
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PP associated with SR may be mediated in part by a
reduction in the stiffness of the large elastic arteries in the
central circulation.
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